These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 7592875

  • 1. The very low density lipoprotein receptor mediates the cellular catabolism of lipoprotein lipase and urokinase-plasminogen activator inhibitor type I complexes.
    Argraves KM, Battey FD, MacCalman CD, McCrae KR, Gåfvels M, Kozarsky KF, Chappell DA, Strauss JF, Strickland DK.
    J Biol Chem; 1995 Nov 03; 270(44):26550-7. PubMed ID: 7592875
    [Abstract] [Full Text] [Related]

  • 2. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro.
    Medh JD, Bowen SL, Fry GL, Ruben S, Andracki M, Inoue I, Lalouel JM, Strickland DK, Chappell DA.
    J Biol Chem; 1996 Jul 19; 271(29):17073-80. PubMed ID: 8663292
    [Abstract] [Full Text] [Related]

  • 3. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. Evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor.
    Nykjaer A, Kjøller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF, van Zonneveld AJ, Gliemann J, Andreasen PA.
    J Biol Chem; 1994 Oct 14; 269(41):25668-76. PubMed ID: 7929271
    [Abstract] [Full Text] [Related]

  • 4. Very low density lipoprotein receptor binds and mediates endocytosis of urokinase-type plasminogen activator-type-1 plasminogen activator inhibitor complex.
    Heegaard CW, Simonsen AC, Oka K, Kjøller L, Christensen A, Madsen B, Ellgaard L, Chan L, Andreasen PA.
    J Biol Chem; 1995 Sep 01; 270(35):20855-61. PubMed ID: 7657671
    [Abstract] [Full Text] [Related]

  • 5. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor.
    Rodenburg KW, Kjoller L, Petersen HH, Andreasen PA.
    Biochem J; 1998 Jan 01; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275
    [Abstract] [Full Text] [Related]

  • 6. gp330 on type II pneumocytes mediates endocytosis leading to degradation of pro-urokinase, plasminogen activator inhibitor-1 and urokinase-plasminogen activator inhibitor-1 complex.
    Stefansson S, Kounnas MZ, Henkin J, Mallampalli RK, Chappell DA, Strickland DK, Argraves WS.
    J Cell Sci; 1995 Jun 01; 108 ( Pt 6)():2361-8. PubMed ID: 7673355
    [Abstract] [Full Text] [Related]

  • 7. Cellular catabolism of normal very low density lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is induced by the C-terminal domain of lipoprotein lipase.
    Chappell DA, Inoue I, Fry GL, Pladet MW, Bowen SL, Iverius PH, Lalouel JM, Strickland DK.
    J Biol Chem; 1994 Jul 08; 269(27):18001-6. PubMed ID: 7517936
    [Abstract] [Full Text] [Related]

  • 8. The second and fourth cluster of class A cysteine-rich repeats of the low density lipoprotein receptor-related protein share ligand-binding properties.
    Neels JG, van Den Berg BM, Lookene A, Olivecrona G, Pannekoek H, van Zonneveld AJ.
    J Biol Chem; 1999 Oct 29; 274(44):31305-11. PubMed ID: 10531329
    [Abstract] [Full Text] [Related]

  • 9. LDL receptor family-dependent and -independent pathways for the internalization and digestion of lipoprotein lipase-associated beta-VLDL by rat vascular smooth muscle cells.
    Weaver AM, Lysiak JJ, Gonias SL.
    J Lipid Res; 1997 Sep 29; 38(9):1841-50. PubMed ID: 9323593
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
    Horn IR, Moestrup SK, van den Berg BM, Pannekoek H, Nielsen MS, van Zonneveld AJ.
    J Biol Chem; 1995 May 19; 270(20):11770-5. PubMed ID: 7538122
    [Abstract] [Full Text] [Related]

  • 11. Binding areas of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex for endocytosis receptors of the low-density lipoprotein receptor family, determined by site-directed mutagenesis.
    Skeldal S, Larsen JV, Pedersen KE, Petersen HH, Egelund R, Christensen A, Jensen JK, Gliemann J, Andreasen PA.
    FEBS J; 2006 Nov 19; 273(22):5143-59. PubMed ID: 17042782
    [Abstract] [Full Text] [Related]

  • 12. Structure-function relationship of lipoprotein lipase-mediated enhancement of very low density lipoprotein binding and catabolism by the low density lipoprotein receptor. Functional importance of a properly folded surface loop covering the catalytic center.
    Salinelli S, Lo JY, Mims MP, Zsigmond E, Smith LC, Chan L.
    J Biol Chem; 1996 Sep 06; 271(36):21906-13. PubMed ID: 8702993
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the ligand binding activity of the human very low density lipoprotein receptor by protein kinase C-dependent phosphorylation.
    Sakthivel R, Zhang JC, Strickland DK, Gåfvels M, McCrae KR.
    J Biol Chem; 2001 Jan 05; 276(1):555-62. PubMed ID: 11010963
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S, Suzuki J, Kohno M, Oida K, Tamai T, Miyabo S, Yamamoto T, Nakai T.
    J Biol Chem; 1995 Jun 30; 270(26):15747-54. PubMed ID: 7797576
    [Abstract] [Full Text] [Related]

  • 15. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro.
    Webb DJ, Nguyen DH, Sankovic M, Gonias SL.
    J Biol Chem; 1999 Mar 12; 274(11):7412-20. PubMed ID: 10066806
    [Abstract] [Full Text] [Related]

  • 16. Molecular analysis of ligand binding to the second cluster of complement-type repeats of the low density lipoprotein receptor-related protein. Evidence for an allosteric component in receptor-associated protein-mediated inhibition of ligand binding.
    Horn IR, van den Berg BM, van der Meijden PZ, Pannekoek H, van Zonneveld AJ.
    J Biol Chem; 1997 May 23; 272(21):13608-13. PubMed ID: 9153209
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The 39-kDa receptor-associated protein modulates lipoprotein catabolism by binding to LDL receptors.
    Medh JD, Fry GL, Bowen SL, Pladet MW, Strickland DK, Chappell DA.
    J Biol Chem; 1995 Jan 13; 270(2):536-40. PubMed ID: 7822276
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.